Follow-up study on 24 patients with nomifensine-induced
immune haemolytic
anaemia
by
Giers G, Salama A, Mueller-Eckhardt C
Institute for Clinical Immunology
and Transfusion Medicine,
Justus Liebig
University Giessen, Germany.
Transfus Med 1991 Jun; 1(2):115-9
ABSTRACT
There is as yet only scarce information regarding the natural history and
long-term clinical sequelae of patients who survive the acute complications of
severe drug-related immune haemolysis, the effect of the mode of drug
administration for sensitization and possible alterations of serological
characteristics of drug-dependent antibodies during the postsensitization
period. We therefore followed 24 patients with nomifensine-induced haemolytic
anaemia for up to 6 years after the haemolytic attack. All patients had suffered
from a severe haemolytic episode. None of the patients showed any abnormal
findings upon reinvestigation (complete history and physical examination;
extended biochemical and haematological laboratory status), particularly with
respect to renal function. Drug-dependent antibodies remained detectable in 19
of 21 sera, while drug-independent autoantibodies, demonstrable in six patients
during the acute phase of haemolysis, could no longer be detected. With regard
to the mode of drug administration, the majority of patients (15 out of 24) had
developed the haemolysis at the beginning (immediately after a single dose) or
during a second course of drug therapy (n = 8 and 7, respectively). The immune
response did not appear to be dose- or time-dependent. This study confirms the
benign long-term prognosis of patients who survive life-threatening
complications in drug-induced immune haemolytic anaemia. In addition, it
indicates that drug-dependent antibodies may remain detectable over long periods
of time, and that irregular drug administration might be associated with a
higher risk of drug sensitization.
Dopamine
Bupropion
Amineptine
Noradrenaline
Methylphenidate
Nomifensine dependence
Nomifensine versus imipramine
Nomifensine, bupropion and cocaine
Nomifensine-induced immune hemolysis
Nomifensine, dopamine and noradrenaline
Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative

The Good Drug Guide
The Responsible Parent's Guide To
Healthy Mood Boosters For All The Family